Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Virica Biotech Inc. — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Virica Biotech and Ginkgo Bioworks Partner to Enhance AAV Gene Therapy Manufacturing

Oct 03, 2024•over 1 year ago

Contract Type

partnership

OttawaBiotechnology

Description

Virica Biotech Inc. and Ginkgo Bioworks, Inc. announced a strategic partnership to enhance each company’s adeno-associated virus (AAV) gene therapy manufacturing platforms. This collaboration aims to tackle the high cost of AAV-based gene therapies manufacturing, leveraging the advanced capabilities of both companies to reduce production costs and make gene therapies more accessible to patients.

Company Information

Company

Virica Biotech Inc.

Location

7 BAYVIEW STATION ROAD

Ottawa, Michigan, United States

About

Virica Biotech is a biotechnology company that addresses the unmet needs in production and development to positively change human health. Its Viral Sensitizer technology consists of a library of over one hundred small molecules that can safely overcome the natural immunological defenses in the human and animal body that suppress effective viralmedicines.

Predictive Intelligence
Strategic

ML-powered predictions for Virica Biotech Inc.'s next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months